Details of the Drug
General Information of Drug (ID: DM00180)
| Drug Name |
DABO-1047
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
DABOs Universita Di Roma; DABOs Universita Di Siena; DABO derivatives, Idenix; DABO-1220; DABOs, Idenix; DABOs, Novirio; DABOs, Universita di Cagliari; Dihydroalkoxybenzyloxopyrimidines, Idenix; Dihydroalkoxybenzyloxopyrimidines, Novirio; HIV reverse transcriptase inhibitors, Idenix; MC-1008; MC-1047; MC-1145; MC-1220; MC-442; MC-849; MC-867; MC-922; MeSMe-DABO Universita Di Cagliari; Anti-HIV therapeutics, Idenix
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Structure | 3D Structure is Not Available |
![]() |
|||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

